Preoperative evaluation and perioperative management of right ventricular failure after left ventricular assist device implantation

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 17, Issue 4, 2013, Pages 249-261

  Marzec, Lucas N ^a   Ambardekar, Amrut V ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

heart failure; left ventricular assist device (LVAD); mechanical circulatory support; right ventricle

Indexed keywords

INOTROPIC AGENT; VASODILATOR AGENT;

ECHOCARDIOGRAPHY; HEART ASSIST DEVICE; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; HUMAN; IMPLANTATION; LABORATORY DIAGNOSIS; MORBIDITY; MORTALITY; PATIENT SELECTION; PEROPERATIVE CARE; PREOPERATIVE EVALUATION; REVIEW;

HEART FAILURE; LEFT VENTRICULAR ASSIST DEVICE (LVAD); MECHANICAL CIRCULATORY SUPPORT; RIGHT VENTRICLE;

HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INCIDENCE; PATIENT SELECTION; PERIOPERATIVE CARE; PREOPERATIVE CARE; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84887983164     PISSN: 10892532     EISSN: 19405596     Source Type: Journal    
DOI: 10.1177/1089253213488246     Document Type: Review

References (50)

1. Kirklin JK, Naftel DC, Kormos RL, et al. The fourth INTERMACS annual report: 4,000 implants and counting. J Heart Lung Transplant. 2012 ; 31: 117-126
2. Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010 ; 139: 1316-1324
3. Drakos SG, Janicki L, Horne BD, et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol. 2010 ; 105: 1030-1035
4. Dang NC, Topkara VK, Mercando M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006 ; 25: 1-6
5. Morgan JA, John R, Lee BJ, Oz MC, Naka Y. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg. 2004 ; 77: 859-863
6. Patel ND, Weiss ES, Schaffer J, et al. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. Ann Thorac Surg. 2008 ; 86: 832-840
7. John R, Liao K, Kamdar F, Eckman P, Boyle A, Colvin-Adams M. Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices. J Thorac Cardiovasc Surg. 2010 ; 140: 447-452
8. Etz CD, Welp HA, Tjan TD, et al. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. Ann Thorac Surg. 2007 ; 83: 1697-1705
9. Ochiai Y, McCarthy PM, Smedira NG, et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation. 2002 ; 106: I-198 - I-202
10. Fukamachi K, McCarthy PM, Smedira NG, Vargo RL, Starling RC, Young JB. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg. 1999 ; 68: 2181-2184
11. Cowger J, Sundareswaran K, Rogers JG, et al. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. J Am Coll Cardiol. 2013 ; 61: 313-321
12. Farrar DJ, Hill JD, Pennington DG, et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg. 1997 ; 113: 202-209
13. Fitzpatrick JR, Frederick JR, Hsu VM, et al. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant. 2008 ; 27: 1286-1292
14. Kavarana MN, Pessin-Minsley MS, Urtecho J, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg. 2002 ; 73: 745-750
15. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007 ; 116: 497-505
16. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008 ; 51: 2163-2172
17. Kato TS, Chokshi A, Singh P, et al. Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure. J Heart Lung Transplant. 2012 ; 31: 37-45
18. Hennig F, Stepanenko AV, Lehmkuhl HB, et al. Neurohumoral and inflammatory markers for prediction of right ventricular failure after implantation of a left ventricular assist device. Gen Thorac Cardiovasc Surg. 2011 ; 59: 19-24
19. Kukucka M, Stepanenko A, Potapov E, Krabatsch T, Kuppe H, Habazettl H. Impact of tricuspid valve annulus dilation on mid-term survival after implantation of a left ventricular assist device. J Heart Lung Transplant. 2012 ; 31: 967-971
20. Potapov EV, Stepanenko A, Dandel M, et al. Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J Heart Lung Transplant. 2008 ; 27: 1275-1281
21. Puwanant S, Hamilton KK, Klodell CT, et al. Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation. J Heart Lung Transplant. 2008 ; 27: 1102-1107
22. Topilsky Y, Oh JK, Shah DK, et al. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation. JACC Cardiovasc Imaging. 2011 ; 4: 211-222
23. Kukucka M, Stepanenko A, Potapov E, et al. Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2011 ; 30: 64-69
24. Grant AD, Smedira NG, Starling RC, Marwick TH. Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol. 2012 ; 60: 521-528
25. Wang Y, Simon MA, Bonde P, et al. Decision tree for adjuvant right ventricular support in patients receiving a left ventricular assist device. J Heart Lung Transplant. 2012 ; 31: 140-149
26. Teuteberg JJ, Ewald GA, Adamson RM, et al. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients. J Am Coll Cardiol. 2012 ; 60: 44-51
27. Subramaniam K, Yared JP. Management of pulmonary hypertension in the operating room. Semin Cardiothorac Vasc Anesth. 2007 ; 11: 119-136
28. Slaughter MS, Pagani FD, Rogers JG, et al. HeartMate II Clinical Investigators. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010 ; 29: S1 - S39
29. Kukucka M, Potapov E, Stepanenko A, et al. Acute impact of left ventricular unloading by left ventricular assist device on the right ventricle geometry and function: effect of nitric oxide inhalation. J Thorac Cardiovasc Surg. 2011 ; 141: 1009-1014
30. George I, Xydas S, Topkara VK, et al. Clinical indication for use and outcomes after inhaled nitric oxide therapy. Ann Thorac Surg. 2006 ; 82: 2161-2169
31. Wagner F, Dandel M, Gunther G, et al. Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation. Circulation. 1997 ; 96: II-291 - II-296
32. Argenziano M, Choudhri AF, Moazami N, et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg. 1998 ; 65: 340-345
33. De Wet CJ, Affleck DG, Jacobsohn E, et al. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J Thorac Cardiovasc Surg. 2004 ; 127: 1058-1067
34. Augoustides JG, Ochroch EA. Pro: inhaled prostaglandin as a pulmonary vasodilator instead of nitric oxide. J Cardiothorac Vasc Anesth. 2005 ; 19: 400-402
35. Dickstein ML. Con: inhaled prostaglandin as a pulmonary vasodilator instead of nitric oxide. J Cardiothorac Vasc Anesth. 2005 ; 19: 403-405
36. Klodell CT, Morey TE, Lobato EB, et al. Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices. Ann Thorac Surg. 2007 ; 83: 68-71
37. Tedford RJ, Hemnes AR, Russell SD, et al. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail. 2008 ; 1: 213-219
38. Saeed D, Kidambi T, Shalli S, et al. Tricuspid valve repair with left ventricular assist device implantation: is it warranted?. J Heart Lung Transplant. 2011 ; 30: 530-535
39. Krishan K, Nair A, Pinney S, Adams DH, Anyanwu AC. Liberal use of tricuspid-valve annuloplasty during left-ventricular assist device implantation. Eur J Cardiothorac Surg. 2012 ; 41: 213-217
40. Piacentino V, Ganapathi AM, Stafford-Smith M, et al. Utility of concomitant tricuspid valve procedures for patients undergoing implantation of a continuous-flow left ventricular device. J Thorac Cardiovasc Surg. 2012 ; 144: 1217-1221
41. Stulak JM, Romans T, Cowger J, et al. Delayed sternal closure does not increase late infection risk in patients undergoing left ventricular assist device implantation. J Heart Lung Transplant. 2012 ; 31: 1115-1119
42. Fitzpatrick JR, Frederick JR, Hiesinger W, et al. Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J Thorac Cardiovasc Surg. 2009 ; 137: 971-977
43. Bhama JK, Kormos RL, Toyoda Y, Teuteberg JJ, McCurry KR, Siegenthaler MP. Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. J Heart Lung Transplant. 2009 ; 28: 971-976
44. John R, Long JW, Massey HT, et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011 ; 141: 932-939
45. Kapur NK, Paruchuri V, Korabathina R, et al. Effects of a percutaneous mechanical circulatory support device for medically refractory right ventricular failure. J Heart Lung Transplant. 2011 ; 30: 1360-1367
46. Takagaki M, Wurzer C, Wade R, et al. Successful conversion of TandemHeart left ventricular assist device to right ventricular assist device after implantation of a HeartMate XVE. Ann Thorac Surg. 2008 ; 86: 1677-1679
47. Sugiki H, Nakashima K, Vermes E, Loisance D, Kirsch M. Temporary right ventricular support with Impella Recover RD axial flow pump. Asian Cardiovasc Thorac Ann. 2009 ; 17: 395-400
48. Hetzer R, Krabatsch T, Stepanenko A, Hennig E, Potapov EV. Long-term biventricular support with the HeartWare implantable continuous flow pump. J Heart Lung Transplant. 2010 ; 29: 822-824
49. Strueber M, Meyer AL, Malehsa D, Haverich A. Successful use of the HeartWare HVAD rotary blood pump for biventricular support. J Thorac Cardiovasc Surg. 2010 ; 140: 936-937
50. Loforte A, Montalto A, Della Monica PL, Contento C, Musumeci F. Biventricular support with the HeartWare implantable continuous flow pump: an additional contribution. J Heart Lung Transplant. 2010 ; 29: 1443-1444